Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
long-acting beta2-adrenergic agonist |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
R03AC12
|
| gptkbp:brand |
gptkb:Serevent
|
| gptkbp:CASNumber |
89365-50-4
|
| gptkbp:contraindication |
hypersensitivity to salmeterol
|
| gptkbp:discoveredBy |
gptkb:Allen_&_Hanburys
|
| gptkbp:eliminationHalfLife |
5.5 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:hasMolecularFormula |
C25H37NO4
|
| https://www.w3.org/2000/01/rdf-schema#label |
salmeterol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
beta2-adrenergic receptor agonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:proteinBinding |
94-98%
|
| gptkbp:PubChem_CID |
5202
DB00938 |
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
headache
muscle cramps throat irritation |
| gptkbp:UNII |
QIX5X066YK
|
| gptkbp:usedFor |
asthma
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:Advair
gptkb:Seretide gptkb:ADRB2_gene gptkb:beta-2_adrenergic_receptor |
| gptkbp:bfsLayer |
7
|